Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Nature|September 14, 2017
Alternative evolutionary histories in the sequence space of an ancient proteinTyler N Starr, Lora K Picton, Joseph W ThorntonMethods in Molecular Biology (Clifton, N.J.)|June 13, 2020
Isolation and Analysis of Mitochondrial Fission Enzyme DNM1 from Saccharomyces cerevisiaeNolan W Kennedy, Lora K Picton, R Blake HillACS Synthetic Biology|April 3, 2023
Receptor Elimination by E3 Ubiquitin Ligase Recruitment (REULR): A Targeted Protein Degradation ToolboxDirk H Siepe, Lora K Picton, K Christopher GarciaBiochemistry|June 16, 2009
Evidence for conformational heterogeneity of fission protein Fis1 from Saccharomyces cerevisiaeLora K Picton, Salvador Casares, Ann C Monahan, et al.ACS Synthetic Biology|September 28, 2022
Induced CD45 Proximity Potentiates Natural Killer Cell Receptor AntagonismJunming Ren, Yeara Jo, Lora K Picton, et al.The Journal of Biological Chemistry|September 22, 2007
Direct binding of the dynamin-like GTPase, Dnm1, to mitochondrial dynamics protein Fis1 is negatively regulated by the Fis1 N-terminal armRobert C Wells, Lora K Picton, Sarah C P Williams, et al.Journal of Virology|December 26, 2008
Role of conserved cysteines in the alphavirus E3 proteinMegan M Parrott, Sarah A Sitarski, Randy J Arnold, et al.Journal of Molecular Biology|July 14, 2012
A designed point mutant in Fis1 disrupts dimerization and mitochondrial fissionJonathan P B Lees, Cara Marie Manlandro, Lora K Picton, et al.Proceedings of the National Academy of Sciences of the United States of America|March 16, 2022
Interleukin-2 superkines by computational designJunming Ren, Alexander E Chu, Kevin M Jude, et al.Proceedings of the National Academy of Sciences of the United States of America|May 19, 2022
Synergy of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I-deficient and MHC I+ tumorsNatalie K Wolf, Cristina Blaj, Lora K Picton, et al.Pageof 3